Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysisReview Published on 2023-04-012023-06-01 Journal: Microbial pathogenesis [Category] 두창, 수두, 홍역, [키워드] EBV HSV Human herpes viruses multiple sclerosis [DOI] 10.1016/j.micpath.2023.106031 [Article Type] Review
Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new fieldArticle Published on 2023-02-012024-09-04 Journal: International Journal of Infectious Diseases [Category] 대상포진, [키워드] CMV COVID-19 EBV HSV SARS-COV-2 infection VZV [DOI] 10.1016/j.ijid.2023.01.036 PMC 바로가기 [Article Type] Article
The impact of HLA polymorphism on herpesvirus infection and diseasearticle Published on 2023-01-032024-09-02 Journal: Curr Top Med Mycol [Category] 대상포진, [키워드] EBV HCMV herpesvirus human leukocyte antigen Immunogenetics VZV [DOI] 10.1007/s00251-022-01288-z PMC 바로가기 [Article Type] article
Dynamics of Viral and Host 3D Genome Structure upon InfectionReview Published on 2022-12-282023-07-10 Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), [키워드] Chromatin structure EBV HIV HPV Influenza virus KSHV SARS-CoV-2 [DOI] 10.4014/jmb.2208.08020 PMC 바로가기 [Article Type] Review
The neurobiology of long COVIDReview Published on 2022-11-022023-07-10 Journal: Neuron [Category] COVID19(2023년), [키워드] astrocytes Autoimmunity blood-brain-barrier Cognitive impairment COVID-19 EBV hippocampal neurogenesis HSV Long COVID microglia Microvascular disease Myelin PAISs post-acute infection syndromes. SARS-CoV-2 [DOI] 10.1016/j.neuron.2022.10.006 PMC 바로가기 [Article Type] Review
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndromeArticle Published on 2022-10-202022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] analyzed Anti-viral anti-viral antibody antibody Antibody Response baseline chronic disease CMV cohorts COVID-19 EBV elevated fatigue healthy donor herpesvirus herpesvirus reactivation HERV HERV-K HHV6A HSV2 IgG immunoassay latent virus majority ME/CFS mechanisms multiplex Myalgic encephalomyelitis/chronic fatigue syndrome nuclear oral mucosa overlap Patient plasma Post-viral fatigue Reactivation retrovirus risk factor Saliva SARS-COV-2 infection shown significantly sustained Symptom syndrome systemically triggered unique viral infection virus [DOI] 10.3389/fimmu.2022.949787 PMC 바로가기
Long Covid: where we stand and challenges aheadArticle Published on 2022-10-012022-11-15 Journal: Cell Death and Differentiation [Category] COVID19(2023년), SARS, 진단, [키워드] addition Affect Autoimmunity Brain Breakthrough infection cardiovascular system complex defined disease driver EBV Health care system Inflammation initial kidney Long Lungs manifestation mechanism multifactorial organ organs other organ PASC Pathogenesis pathway persistence reduce SARS-CoV-2 SARS-COV-2 infection Symptom therapeutic approaches tissue vaccination virus [DOI] 10.1038/s41418-022-01052-6 PMC 바로가기
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈Article Published on 2022-09-012022-09-11 Journal: Journal of Intensive Care Medicine [Category] 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed ARDS Chain Reaction Characteristics Clinical deterioration CMV cohort study comparable connection control group coronavirus Corticosteroid Course COVID-19 Critically ill Critically ill patient critically ill patients cytomegalovirus decrease described Diagnosis disease EBV Epstein-Barr virus Follow-up analysis Ganciclovir high risk hyperinflammation ICU in viral incidence increased mortality initiation of treatment intensive care intensive care unit majority Non-COVID-19 non-COVID-19 patient Non-COVID-19 patients outcome Patient polymerase chain polymerase chain reaction Reactivation remains uncertain retrospective rituximab SARS-CoV-2 screened Sepsis sepsis patient Sery severe acute respiratory syndrome Coronavirus severe COVID-19 single-center survived systemic corticosteroid treated Treatment Trigger Viral load viral reactivation virus with COVID-19 [DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article
Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study헤르페스 바이러스 감염 및 코로나19 이후 발현: 파일럿 관찰 연구Observational Study Published on 2022-09-012022-09-11 Journal: Rheumatology International [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] abnormality accompanied Activation An autoimmune disease Autoimmune Autoimmune disease Cellular immune response clinical and laboratory features CMV complicate contributing to control group controls Course COVID-19 CRP D-dimer detectable Diseases disorders DNA EBV elevated Epstein–Barr virus exaggerate female Fever headache Herpe herpes Herpes virus herpes viruses herpesvirus herpesviruses high mortality high risk Immunocompromised Infection infections laboratory feature liver enzymes male manifestation median age myalgia Numerous Pathologies Patient Reactivation recruited reported rheumatology SARS-CoV-2 severe COVID-19 Spread subject suppressed syndrome temperature the disease Variation variety virus virus infection [DOI] 10.1007/s00296-022-05146-9 PMC 바로가기 [Article Type] Observational Study
Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 PatientsArticle Published on 2022-08-252022-11-15 Journal: Viruses [Category] 치료기술, [키워드] Activation association Autoimmune disorders blood donor Characteristics Coagulopathies Cohort cohorts complex contribute COVID-19 COVID-19 patient detectable disease EBV Epstein-Barr virus Epstein–Barr virus feature fraction Frequency healthy healthy control herpesvirus HHV-6 Hospitalization Hospitalized Human Human Herpesvirus-6 hyperinflammatory responses Infection Inflammation Inflammatory inflammatory disease Inflammatory mediators marker occurred Pathogenesis Patient patients plasma pulmonary disease quantitative PCR Reactivation reported SARS-CoV-2 subset syndrome tested virus with COVID-19 [DOI] 10.3390/v14091872 PMC 바로가기